Intensified dose of cyclophosphamide with G-CSF support versus standard dose combined with platinum in first-line treatment of advanced ovarian cancer a randomised study from the GINECO group.

Br J Cancer · 2007 · PMC2360456 · PMID 17923867

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

at the limit of significanceno p-value reported

However, the benefit of platinum combinations compared to single-agent platinum has long been debated; the analysis published by the Advanced Ovarian Cancer Trialists Group showed that the difference between the two regimens was at the limit of significance (ORR 0.85; CI 95%: 0.72–1.00) ( AOCT, 1991 ).

also in 326 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.